Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Liabilities (2020 - 2025)

Agilon Health (AGL) has disclosed Total Liabilities for 6 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 9.38% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Dec 2025, down 9.38%, and an annual FY2025 reading of $1.1 billion, down 9.38% over the prior year.
  • Total Liabilities was $1.1 billion for Q4 2025 at Agilon Health, down from $1.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.6 billion in Q1 2024 and bottomed at -$879.4 million in Q2 2023.
  • Average Total Liabilities over 5 years is $840.8 million, with a median of $932.5 million recorded in 2022.
  • The sharpest move saw Total Liabilities plummeted 219.3% in 2023, then soared 269.13% in 2024.
  • Year by year, Total Liabilities stood at $494.7 million in 2021, then surged by 32.79% to $656.9 million in 2022, then skyrocketed by 64.4% to $1.1 billion in 2023, then grew by 16.96% to $1.3 billion in 2024, then decreased by 9.38% to $1.1 billion in 2025.
  • Business Quant data shows Total Liabilities for AGL at $1.1 billion in Q4 2025, $1.3 billion in Q3 2025, and -$408.9 million in Q2 2025.